Levonorgestrel and ethinyl estradiol (LNG/EE) are two active ingredients used in combination in many modern birth control pills. This combination of hormones has been used in oral contraceptives for over 50 years and is one of the most commonly prescribed medications for women’s health. In this article, we will explore the benefits of LNG/EE for women’s health, including its contraceptive benefits, its potential to reduce the risk of certain cancers, and its ability to reduce the risk of developing certain medical conditions.
The primary benefit of LNG/EE is its contraceptive effect. It works by preventing ovulation, which means that the egg is not released from the ovary and therefore cannot be fertilized. This means that pregnancy is prevented. The contraceptive effect of LNG/EE is highly effective when taken as directed, with a failure rate of less than 1%. This makes it one of the most reliable methods of contraception available. In addition to its contraceptive benefits, LNG/EE can also help to regulate the menstrual cycle, making it more regular and reducing the risk of irregular bleeding.
In addition to its contraceptive benefits, LNG/EE has also been shown to reduce the risk of certain cancers. Studies have shown that LNG/EE can reduce the risk of ovarian cancer by up to 50%. It has also been shown to reduce the risk of endometrial cancer, which is cancer of the lining of the uterus, by up to 30%. This is an important benefit for women, as these types of cancer can be life-threatening.
In addition to its contraceptive and cancer risk reduction benefits, LNG/EE can also reduce the risk of developing certain medical conditions. Studies have shown that LNG/EE can reduce the risk of developing pelvic inflammatory disease, a serious infection of the reproductive organs, by up to 70%. It has also been shown to reduce the risk of developing benign breast disease, which can lead to breast cancer, by up to 50%. This is an important benefit for women, as these medical conditions can have serious implications for their health.
Levonorgestrel and ethinyl estradiol (LNG/EE) are two active ingredients used in combination in many modern birth control pills. This combination of hormones has been used in oral contraceptives for over 50 years and is one of the most commonly prescribed medications for women’s health. In this article, we have explored the benefits of LNG/EE for women’s health, including its contraceptive benefits, its potential to reduce the risk of certain cancers, and its ability to reduce the risk of developing certain medical conditions. Overall, LNG/EE is an effective and reliable form of contraception that can also provide additional benefits for women’s health.
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.
3.
Is a $2,000 Whole-Body MRI Worth It?
4.
Surgery may not be necessary to treat invasive breast cancer
5.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
1.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
2.
Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective
3.
Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know
4.
Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post
5.
Understanding Lymphedema: Symptoms, Causes, and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
4.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation